{"slug":"semax-glp1-gut","verification":{"valid":true,"entries":2,"head":"8f0f078ba6688939221cacd7841f75f806f766af8775cfda4bc5c0e839f9f748"},"energy":{"passes":2,"tokens_in":13959,"tokens_out":3021,"tokens_total":16980,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"8f0f078ba6688939221cacd7841f75f806f766af8775cfda4bc5c0e839f9f748"},"provenance":[{"ts":"2026-06-30T00:10:57.133Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Semax for Glp1 Gut\nSlug: semax-glp1-gut\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"GLP-1 gut damage / gastroparesis\",\"condition_key\":\"glp1-gut-damage\",\"primary_peptide\":\"semax\",\"peptides_in_scope\":[{\"id\":\"semax\",\"name\":\"Semax\"}],\"drugs_in_scope\":[\"glp1-agonists\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have GLP-1 gut damage / gastroparesis\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"semax\",\"name\":\"Semax\",\"section_title\":\"Why Semax might help you\",\"layer\":\"neural / cognitive\",\"steps\":[\"You are reading about **GLP-1 gut damage / gastroparesis** — what breaks down matters before any compound name.\",\"**What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\",\"**What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\",\"**Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\"],\"prose\":\"1. You are reading about **GLP-1 gut damage / gastroparesis** — what breaks down matters before any compound name.\\n2. **What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\\n3. **What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating sympt","response":"{\n  \"slug\": \"semax-glp1-gut\",\n  \"title\": \"Semax for GLP-1 Gut Damage: Evidence on Neural and Gastroprotective Pathways\",\n  \"body\": \"## What's breaking down if you have GLP-1 gut damage / gastroparesis\\n\\nGLP-1 agonists slow gastric emptying as part of their mechanism. This can lead to persistent nausea, bloating, and in some cases diagnosed gastroparesis. The stomach muscles and vagus nerve signaling weaken or desynchronize. Repair of motility and gut-brain communication lags behind the drug-induced suppression. When breakdown outruns repair, symptoms persist even after dose adjustments.\\n\\n## Why Semax might help you\\n\\n1. You are reading about GLP-1 gut damage / gastroparesis — what breaks down matters before any compound name.\\n2. What keeps failing: BDNF decline can blunt neural plasticity along the gut-brain axis; autonomic signaling to the stomach may stay impaired after GLP-1 exposure.\\n3. What Semax is studied to do: It is studied for BDNF upregulation and neural support in brain regions tied to autonomic control.\\n4. Therefore for you: If neural repair at the gut-brain interface is part of your problem, Semax is discussed because it targets repair pathways rather than further suppressing motility signals.\\n\\n## Why GLP-1 agonists (class) matters for you\\n\\nGLP-1 agonists deliver metabolic benefits through appetite suppression and slowed gastric emptying. They suppress hunger signals and reduce overall caloric load. For someone with GLP-1 gut damage, this creates a tradeoff: the same slowing that aids weight control can worsen motility issues and delay gastric repair. The drug reduces metabolic load but trades off direct support for gut motility recovery.\\n\\n## How these fit together\\n\\nSingle-compound focus on Semax. The neural / cognitive layer targeted by Semax sits alongside the motility suppression from GLP-1 agonists. Semax addresses BDNF-linked plasticity that may support autonomic recovery, while GLP-1 agonists handle metabolic demand. No multi-pepti","tokens_in":13959,"tokens_out":3021,"cost":0,"prev":"genesis","hash":"78916f2de3720446820336f41d59162257c3846c9847e24306b3d6b7de91873c"},{"ts":"2026-07-17T02:41:54.149Z","model":"owner","action":"voxel_divide","prompt":"","input":"semax-glp1-gut","response":"20 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"78916f2de3720446820336f41d59162257c3846c9847e24306b3d6b7de91873c","hash":"8f0f078ba6688939221cacd7841f75f806f766af8775cfda4bc5c0e839f9f748"}]}